Amplia Therapeutics (ASX: ATX) develops new approach to treat cancer and fibrosis (w/ John Lambert)

Small Caps - A podcast by Small Caps

Amplia Therapeutics (ASX: ATX) managing director and CEO John Lambert joins Small Caps to discuss the latest results from the company's...